supporting investigators in TTFields clinical trials

Jonathan Gephart, Senior Clinical Research Scientist

Jonathan Gephart, a Florida-based Senior Clinical Research Scientist, said trust, one of Novocure’s six core values, is essential to his role.

 

“The key to my profession is being a reliable source of information,” Jonathan said.

Jonathan develops and maintains relationships with the scientific community and shares the science behind Tumor Treating Fields (TTFields). He builds trust by prioritizing accuracy and accountability.

 

As Novocure begins new clinical trials, many participating physicians are using TTFields therapy for the first time to treat their patients. To assist these clinical investigators, Jonathan educates them on the science and administration of TTFields therapy, which involves placing arrays on the skin of patients to deliver the therapy locally to the tumor.

 

“Forming a relationship built on trust with investigators and their staff is the foundation of my work,” he sai

Jonathan Gephart, Senior Clinical Research Scientist, said as a medical device company, it’s crucial that we are a trusted source for our stakeholders.

The key to my profession is being a reliable source of information.

— Jonathan Gephart, Senior Clinical Research Scientist

careers at Novocure

We are a global community of passionate, talented, committed and caring people working together to make a difference in the way cancer is treated.

learn more

our clinical pipeline

We are committed to advancing the science of Tumor Treating Fields across a broad spectrum of solid tumors and bringing our therapy to cancer patients who may benefit.

learn more

our culture

read all stories

Novocure Websites

On this site, videos and images identified as Optune users, caregivers or healthcare professionals depict actual patients, caregivers and healthcare professionals. Patient images reflect the health status of the patients at the time each photo or video was taken.

 

 

 

 



Quick links

about us
our therapy
our pipeline
investors relations
careers
news and media
patient-forward

© 2025 Novocure GmbH all rights reserved

GLB-CC-00272 v1.0 February 2025